Bi-yang Cao
Beijing, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer" [Radiother. Oncol. 213 (2025) 111210].
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 15, 2026
Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 16, 2025
Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer.
Journal: BMC cancer
Published: January 12, 2025
Survival benefits of radiotherapy in locally advanced unresectable and metastatic pancreatic cancer: a single-institution cohort and SEER database analysis.
Journal: Frontiers in oncology
Published: July 30, 2024
Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer.
Journal: World journal of gastroenterology
Published: January 19, 2024
Human epidermal growth factor receptor 2 expression level and combined positive score can evaluate efficacy of advanced gastric cancer.
Journal: World journal of clinical oncology
Published: January 02, 2024
Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma.
Journal: World journal of gastrointestinal oncology
Published: November 14, 2022
Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis.
Journal: World journal of gastrointestinal oncology
Published: November 02, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026